[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1980

Acyclovir Topical Therapy of Cutaneous Herpes Simplex Virus Infection in Guinea Pigs

Author Affiliations

From the Department of Cornea Research, Eye Research Institute of Retina Foundation (Drs Park, Pavan-Langston, and Lass, and Ms McLean) and the Department of Ophthalmology, Harvard Medical School (Drs Park, Pavan-Langston, and Lass), Boston.

Arch Dermatol. 1980;116(6):672-675. doi:10.1001/archderm.1980.01640300060018
Abstract

• The chemotherapeutic efficacy of acyclovir was evaluated by observing the potential of topical acyclovir to reduce the severity of herpes viral lesions and to control the multiplication of this virus in the experimentally induced primary cutaneous infection of guinea pigs. Topical acyclovir showed a substantially high therapeutic efficacy when treatment was initiated after the development of clinically overt skin lesions. The therapeutic response was dose dependent and clearly evident even when the treatment was initiated on day 2 after inoculation. Our results indicate that topical acyclovir treatment improved the cutaneous herpes simplex virus type 1 (HSV-1) infectious process by inhibiting multiplication of HSV-1 in the skin of guinea pigs.

(Arch Dermatol 116:672-675, 1980)

×